Polymyositis associated with infliximab treatment for rheumatoid arthritis.
Musiał
J
J
Undas
A
A
Celińska-Lowenhoff
M
M
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D017285:Polymyositis / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab